Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes
This continuing education (CE) course will educate a national audience of healthcare providers (physicians, pharmacists, nurses, and others) about the reduction of hypoglycemic events in Type 2 diabetes.
CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health.
Learn more on FDA's Training and Continuing Education webpage.
Resources for You
(855) 543-3784, or